Clinical and Molecular Study of Endometriosis and Adenomyosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-42
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.
Eligibility criteria
Qualifiers
Women of age between - 18 and 42 years old.
In-service care for one of the pelvic pain and/or infertility, or for a pelvic mass.
Having a radiological diagnosis made by a referral practitioner and/or operated in the department
Disqualifiers
HIV-positive women, HBV and HCV
During pregnancy
Having a cancer diagnosis
Refusing to sign a consent.
Trial design
Treatments tested in this trial
- Biological/Vaccine
Treatment groups
5,300 Participants
are divided into 1 treatment groupSponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
URC-CIC Paris Descartes Necker Cochin
Collaborator
Source ClinicalTrials.gov